{"id":597,"date":"2020-01-20T12:05:06","date_gmt":"2020-01-20T11:05:06","guid":{"rendered":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/?p=597"},"modified":"2020-01-20T12:06:39","modified_gmt":"2020-01-20T11:06:39","slug":"picato-en-el-tractament-de-la-queratosi-actinica-suspensio-provisional-de-la-comercialitzacio","status":"publish","type":"post","link":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/picato-en-el-tractament-de-la-queratosi-actinica-suspensio-provisional-de-la-comercialitzacio\/","title":{"rendered":"Picato\u00ae en el tractament de la queratosi act\u00ednica: suspensi\u00f3 provisional de la comercialitzaci\u00f3"},"content":{"rendered":"<p><img loading=\"lazy\" class=\"wp-image-264 alignright\" src=\"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-content\/uploads\/sites\/5\/2019\/01\/logo_aemps.jpg\" alt=\"\" width=\"242\" height=\"117\" srcset=\"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-content\/uploads\/sites\/5\/2019\/01\/logo_aemps.jpg 151w, http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-content\/uploads\/sites\/5\/2019\/01\/logo_aemps-150x72.jpg 150w\" sizes=\"(max-width: 242px) 100vw, 242px\" \/>La queratosi act\u00ednica \u00e9s una alteraci\u00f3 cut\u00e0nia\u00a0\u00a0associada a l&#8217;exposici\u00f3 solar cr\u00f2nica que apareix sobretot en persones d&#8217;edat avan\u00e7ada de pell clara. Algunes lesions poden progressar a un carcinoma espinocel\u00b7lular. El Picato\u00ae (ingenol mebutato) est\u00e0 autoritzat per al tractament de la queratosis act\u00ednica sense hiperqueratosi ni hipertr\u00f2fia.<\/p>\n<p>Els resultats d\u2019estudis recents mostren un augment del risc de carcinoma cutani en pacients tractats amb el f\u00e0rmac. L\u2019Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS) informa, en una <a href=\"https:\/\/www.aemps.gob.es\/informa\/notasinformativas\/medicamentosusohumano-3\/seguridad-1\/%e2%96%bcpicato-ingenol-mebutato-suspension-de-comercializacion-como-medida-de-precaucion-mientras-finaliza-la-evaluacion-europea-en-curso\/\">nota<\/a>, de la suspensi\u00f3 de la comercialitzaci\u00f3 mentre finalitza l\u2019avaluaci\u00f3 de la seva seguretat per part del comit\u00e8 de farmacovigil\u00e0ncia europeu (PRAC). Com a mesura de precauci\u00f3 es recomana:<\/p>\n<p>-suspendre els tractaments actuals,<\/p>\n<p>&#8211; no iniciar-ne de nous i valorar les alternatives terap\u00e8utiques, \u00a0i<\/p>\n<p>&#8211; informar en cas d\u2019aparici\u00f3 de noves lesions.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La queratosi act\u00ednica \u00e9s una alteraci\u00f3 cut\u00e0nia\u00a0\u00a0associada a l&#8217;exposici\u00f3 solar cr\u00f2nica que apareix sobretot en persones d&#8217;edat avan\u00e7ada de pell clara. Algunes lesions poden progressar a un carcinoma espinocel\u00b7lular. El Picato\u00ae (ingenol mebutato) est\u00e0 autoritzat per al tractament de la &hellip; <a href=\"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/picato-en-el-tractament-de-la-queratosi-actinica-suspensio-provisional-de-la-comercialitzacio\/\">Continua llegint <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[19],"tags":[149,483,550,552,242,365,5,554,203],"_links":{"self":[{"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/posts\/597"}],"collection":[{"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/comments?post=597"}],"version-history":[{"count":3,"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/posts\/597\/revisions"}],"predecessor-version":[{"id":600,"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/posts\/597\/revisions\/600"}],"wp:attachment":[{"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/media?parent=597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/categories?post=597"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/tags?post=597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}